ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TRX Tissue Regenix Group Plc

61.50
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tissue Regenix Group Plc LSE:TRX London Ordinary Share GB00BNTXR104 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 61.50 61.00 62.00 61.50 61.50 61.50 8,548 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 24.48M -2.7M -0.0382 -16.10 43.4M
Tissue Regenix Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker TRX. The last closing price for Tissue Regenix was 61.50p. Over the last year, Tissue Regenix shares have traded in a share price range of 49.00p to 71.50p.

Tissue Regenix currently has 70,574,468 shares in issue. The market capitalisation of Tissue Regenix is £43.40 million. Tissue Regenix has a price to earnings ratio (PE ratio) of -16.10.

Tissue Regenix Share Discussion Threads

Showing 8951 to 8973 of 14750 messages
Chat Pages: Latest  362  361  360  359  358  357  356  355  354  353  352  351  Older
DateSubjectAuthorDiscuss
11/8/2017
10:16
Each time I have added more the share price drops further !!
channel pirate
11/8/2017
10:08
But i did! Not showing though?
rayrac
11/8/2017
09:49
Well, perhaps I shouldn't increase my holding?
rayrac
10/8/2017
22:03
That's rather tricky. I wonder how the authorities decide which is which? If it's last in first out then they'd be stuffed. Maybe it's first in first out?
loldemort
10/8/2017
16:32
Still here Ray and was looking to add a few more if we went under 11p to buy but not to be at the moment anyway. From memory I think the II's have to hold their newly acquired shares which they bought at 10p for a whole year. That's not to say they can't offload a few they already had though in order to get some dosh back !!
channel pirate
10/8/2017
16:05
Looks like everyone has abandoned ship!

I've just climbed back on board. 👉🏿🚣🏼R05;♀️🚢

rayrac
10/8/2017
12:05
No comment then? I'm in for a few.
rayrac
08/8/2017
06:54
General Meeting this morning to "rubber stamp" Acquisition:

Due to the size of the Offer, the Offer is conditional, inter alia, on the passing of certain resolutions by shareholders of the Company at a general meeting expected to be convened at the offices of DLA Piper UK LLP, Princes Exchange, Leeds LS1 4BY on Tuesday 8 August 2017 at 9 am (the "General Meeting"). A Circular containing details of the Offer, the Acquisition and the Rule 9 Waiver and the notice of the General Meeting will be sent to shareholders shortly.

Application will be made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM. It is expected that, subject to, inter alia, the passing of the resolutions at the General Meeting, admission to AIM will become effective in respect of, and that dealings on AIM will commence in, the New Ordinary Shares, on or around 9 August 2017.

channel pirate
26/7/2017
14:59
bamboo to be honest I don't have a clue, and would say that your knowledge in these matters is far superior than mine.

See the share price still holding around 11p, but there is another 2 weeks to go before any new shares will be admitted to A.I.M. so plenty of time for the mm's to play around with the share price I'm sitting "on the fence" until then before I decide to add or not.

channel pirate
26/7/2017
12:24
cp, Can the co can process Allografts and Xenografts in the same building?

I think this is why in the UK there is a physical separation in that NHSBT make the Allografts in Speke, while Xenograft is made at HQ in Leeds.

This may not be a problem when it comes to distribution etc. Not really sure.

bamboo2
26/7/2017
07:18
bamboo, have the company said anything definite about xenographs not being a part of the future of the company other than there was a concern about 'shortage' of the products ?

I did realise that the II's were investing pi's money, but the II's also have a reputation to protect, so again I assume a great deal of thought would have been applied before increasing the amount of money they invest into TRX.

Again, with losing the roots of the company, then a great deal of thought will have been applied before changing direction, and one would assume it ultimately would be down to maintaining 'profit' as no profit - no company.

You need to feel comfortable with where you have invested your hard earned money otherwise you will always have a nagging doubt. Reducing your exposure here may be something to consider before selling out completely - hedging your bet !!

If only we all had a Chrystal Ball..............!!

channel pirate
25/7/2017
20:35
cp, glad you were diversified then. Sill a big hit.

TRX, I am concerned about the xenograft products. Without these we face a massive bottleneck in the production area. There is a worldwide shortage of all viable human derived transplant material other than skin.

II's are investing other peoples money, and up to a point, individual investments that fail in small quantities are not a concern, amongst hundreds of others that do average or well.

My concern is that we are losing our roots and the connection with the original idea of the co. This was the work done by Ingham and Fisher.

bamboo2
25/7/2017
20:18
Bamboo, I was diversified then, but after entertaining the M.D.and his wife of CMR in my own home for a whole week-end where I so called learned a lot of what was supposedly going to happen in the next 6 months then the story sounded good.

Coming back to TRX then if you think the share price will fall substantially from here it could be a good call to sell, BUT, the "big boys" have spent a lot of dosh............... Invesco Asset Management Limited acting as agent for its discretionary managed clients including the Invesco Funds ("IAML"), IP Group plc ("IP Group") and Woodford Investment Management Limited acting as agent for its discretionary managed clients ("Woodford") are related parties of the Company for the purposes of the AIM Rules by virtue of their status as substantial shareholders of the Company pursuant to the AIM Rules. Invesco Perpetual High Income Fund and Invesco Perpetual Income Fund (affiliates of IAML), IP2IPO Limited (an affiliate of IP Group) and Woodford have agreed to subscribe for 125,381,588, 50,000,000 and 139,000,000 New Ordinary Shares respectively as part of the Offer, conditional on Admission. Taking into account the related party transactions noted above, the Directors consider, having consulted with Jefferies, the Company's nominated adviser, that the terms of the Placing with such related parties are fair and reasonable in so far as its Shareholders are concerned................. so one would assume they think this to be a good investment. Time will tell, good luck with whatever decision you take.

channel pirate
25/7/2017
17:46
cp, that's a lot to lose in one co. I hope you are diversified now!

I am actively considering selling my TRX shares. I am disappointed that our products do not seem to have got more traction in the market.

What could be better than a transplant that requires no anti-rejection medication? [assuming you need a transplant that is!]

We know that the tech works. Stephan Badylak in the US has proven it time and again in many different animals and people.

We have nearly 12 years of very good, long term results with TRX Heart Valves. Used in children with heart defects, this is the most challenging environment [due to the vigour of a childs immune system] for any graft, other than an auto-graft.

Our Meniscus product is hailed as potentially the 'holy grail' of knee surgeons.

bamboo2
24/7/2017
15:46
After loosing £250K in CMR, then I don't intend repeating it again. I have a self imposed limit (volume of shares) and I will not exceed it, but just hoping I can recover some of the CMR loss here.
channel pirate
24/7/2017
15:29
cp, Please be very careful with it!
bamboo2
24/7/2017
15:26
Either Way, the future looks bright if all goes to plan.

Have a 1 year bond maturing tomorrow (25/07), cash in my bank account on Wednesday, so if we get down to around 10p, then I have another £18K to play with !!

channel pirate
24/7/2017
15:15
cp, True. Big Co would also like some tax credits to offset the cost.

On the other hand, management could get a taste for acquisitions!

bamboo2
24/7/2017
15:07
Well, when the 2 companies are into 1, and generating a positive increasing income, that will make us an attractive target for one of the bigger players out there who might like to take us under their wing !!
channel pirate
24/7/2017
14:53
On the positive side, at least management and staff will now have something to get their teeth into... lol
bamboo2
24/7/2017
14:42
This t/o does completely change the complexion of the co, however, I am not sure what it does for the potential launch of xenografts in the US.

Wonder if xenografts will end up being shelved?

bamboo2
22/7/2017
07:04
bamboo2
Thanks for the link etc. Have just read through the letter from the Chairman and it sounds like the marriage of TRX and CellRight fit together well, making for an enlarged company that if all goes to plan will make us all very happy we hold shares here.

Profitability by 2020, which is only two and a half years off, with rapid growth in the "light of day" as they say.

Happy to hold and add a few more soon.

channel pirate
21/7/2017
22:22
Bit of a roundabout route to find this on the co website. Country of origin to submit, and a few boxes to tick, etc :-/
bamboo2
Chat Pages: Latest  362  361  360  359  358  357  356  355  354  353  352  351  Older

Your Recent History

Delayed Upgrade Clock